RT Journal Article
SR Electronic
T1 Camrelizumab plus gemcitabine and oxaliplatin (GEMOX) in patients with advanced biliary tract cancer: a single-arm, open-label, phase II trial
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e001240
DO 10.1136/jitc-2020-001240
VO 8
IS 2
A1 Chen, Xiaofeng
A1 Wu, Xiaofeng
A1 Wu, Hao
A1 Gu, Yanhong
A1 Shao, Yang
A1 Shao, Qianwen
A1 Zhu, Feipeng
A1 Li, Xiao
A1 Qian, Xiaofeng
A1 Hu, Jun
A1 Zhao, Fengjiao
A1 Mao, Weidong
A1 Sun, Jing
A1 Wang, Jian
A1 Han, Gaohua
A1 Li, Changxian
A1 Xia, Yongxiang
A1 Seesaha, Poshita Kumari
A1 Zhu, Dongqin
A1 Li, Huajun
A1 Zhang, Junling
A1 Wang, Guoqiang
A1 Wang, Xuehao
A1 Li, Xiangcheng
A1 Shu, Yongqian
YR 2020
UL http://jitc.bmj.com/content/8/2/e001240.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.